CIRN continues to function as a network of networks and serves as a primary source of research capacity to provide data to inform public health decision-making about immunization programs to improve the health of Canadians. CIRN’s niche is at the interface of clinical research, surveillance and epidemiological research, and public health program evaluation. CIRN’s focus is on late-stage vaccine evaluation and evaluation of program implementation.
In continuation of the successful PHAC/CIHR Influenza Research Network (PCIRN), from 2009 – 2014, CIRN was funded from June 2015 – May 2017 by a three-year grant of $6.6 million from PHAC and CIHR. A directed CIRN renewal grant application was submitted in February 2017. In April 2017, the network was notified that is fully funded for $10,083,334 over the next 55 months, 2017 – 2022.
The next phase of CIRN hopes to further strengthen Canada’s research capacity, evidence base, and expertise in the field of immunization and vaccines for vaccine-preventable disease. CIRN plays a pivotal role in mentoring early-career researchers, recruiting New Investigators, providing opportunities for trainees, and delivering meaningful engagement of stakeholders at all research stages.
CIRN is led by Dr. Scott Halperin, Nominated Principal Investigator of the network.